The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA.

Cussell, PJG and Howe, MS and Illingworth, TA and Gomez Escalada, M and Milton, NGN and Paterson, AWJ (2019) The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA. PLoS One, 14 (6). ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0217815

Abstract

More Information

Divisions: Faculty of Health and Social Sciences > School of Clinical and Applied Sciences
Identification Number: https://doi.org/10.1371/journal.pone.0217815
Status: Published
Refereed: Yes
Uncontrolled Keywords: MD Multidisciplinary, General Science & Technology,
Depositing User (symplectic) Deposited by Paterson, Andrew
Date Deposited: 12 Jun 2019 08:01
Last Modified: 17 Jun 2019 14:27
Item Type: Article

Download

[img]
Preview
Published Version
| Preview

Export Citation

Share

Statistics

Additional statistics for this record